Embracing technology to help diagnose, treat and monitor Growth Disorders

1st Webinar - 21 June 2024 from 14.00 to 15.00 CEST
2nd Webinar - 20 September 2024 from 14.00 to 15.00 CEST


Clinical examination and experience are key, but can be augmented by team support, genetic techniques and artificial intelligence (AI). The ability to accurately pinpoint the growth defect allows nuanced and personalized care for the patient and their family, and optimal height outcomes.

 Technology also features in patient management, in the form of apps and therapy adherence monitoring which have proven an increase in patient engagement and compliance with medication regimes. The two webinars will be live-streamed, with opportunities for the audience to ask questions and to interact with the Chair and presenters. After each live-stream, a recording of the webinar will be posted online and will be available globally as a free, open-access resource on the MedEA e-learning platform for up to a year after launch.

Learning Objectives

After attending the live webinars participants will be able to:

Target Audience

Pediatricians, endocrinologists and general practitioners involved in growth management.


The official language of this live educational programme will be English. Simultaneous translation into Spanish and Korean will be provided.

Continuing Medical Education

The EMBRACING TECHNOLOGY TO HELP DIAGNOSE, TREAT AND MONITOR GROWTH DISORDERS will be submitted for CME accreditation from the European Accreditation Council for Continuing Medical Education (EACCME©), the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) and for Continuing Professional Development (CPD) credits.

Embracing technology to help diagnose, treat and monitor Growth Disorders

Live Webinar Series
21 June 2024 · from 14.00 to 15.00 CEST

20 September 2024 · from 14.00 to 15.00 CEST


Justin Davies

Justin Davies

Professor of Paediatric Endocrinology
University of Southampton
Southampton, UK
Paul Dimitri

Paul Dimitri

Professor of Child Health Sheffield Children’s Hospital l
University of Sheffield
Sheffield, UK
Richard JM Ross

Richard JM Ross

Professor of Endocrinology
University of Sheffield
Sheffield, UK
Martin O. Savage

Martin O. Savage

Emeritus Professor of Paediatric Endocrinology
William Harvey Research Institute
Barts and the London School of Medicine and Dentistry
Queen Mary, University of London, UK
Luis Fernandez-Luque

Luis Fernandez-Luque

Adhera Health Inc,
Santa Cruz, CA, USA



Final Program

Download STD & Scientific Program

Save the Date
Programme soon


· Justin Davies ·

Justin Davies is a Consultant Paediatric Endocrinologistand Honorary Associate Professorat Southampton Children’s Hospital and the University of Southampton. He is theService Lead for paediatric endocrinology at Southamptonand also leads the Paediatric Metabolic Bone service with a multidisciplinary team dedicated to rare bone disease and childhood osteoporosis. His research interestsinclude secondary osteoporosis, impact of disease on body composition and imprinting disorders.Dr Davies was Chairman of the British Society of Paediatric Endocrinology and Diabetes 2016-2020. He is the service lead for the European Reference Centre -Southampton for Rare Bone Disease and Endocrinology (Growth disorders). His other national roles have included the Secretary of the British Paediatric and Adolescent Bone Group,Treasurer of the British Society of Paediatric Endocrinology and Diabetes.Dr Davies leads an international school for paediatric endocrinology -the European Society for Paediatric Endocrinology, Winter School.

· Richard JM Ross ·

Richard Ross trained in medicine at The Royal London Hospital (1974-1979) and in Endocrinology at St Bartholomew’s Hospital, London (1983-1988). He was appointed to Sheffield University in 1995 and wasHead of the Academic Unit of Diabetes, Endocrinology and Metabolismand is currently Theme Lead for Diabetes and Endocrinology. He retired from clinical practice in June 2020. Hisresearch and clinical interests are in pituitary and adrenal disease, transition endocrinology and the late effects of cancer. Professor Ross has served on the editorial boards of Clinical Endocrinology (1996-2000), Growth & Growth Factors (1986-2006), Hormones (2004-2018), and J Clin Endocrinol Metab (2010-2014). Council member for the Society of Endocrinology (1999-2002), Editor Endocrinologist (2001-2004), Chair of CaHASE (2002-2015), member of the Bioscientifica Board (2006-2010), Society for Endocrinology Public Engagement Committee (2008-2011) and Nominations Committee (2010-2012). Executive Committee of the European Society ofEndocrinology (2011-2015), Treasurer of the European Society of Endocrinology (2013-2015), The Growth Hormone Research Society Council (2011-2018), The Pituitary Society Board of Directors (2019-).He is currently Chief Scientific Officer and Director on the Board of Diurnal Group Plc.

· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 61 countries and has published 472 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.